| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 2,418 shares
@ $27.2493, valued at
$65.9k
Exercised 2,418 options to buy
@ $11.35, valued at
$27.4k
|
|
| 10/04/2023 |
4
| Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 2,200 shares
@ $27.32, valued at
$60.1k
Exercised 2,200 options to buy
@ $5.86, valued at
$12.9k
|
|
| 10/04/2023 |
4
| Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 3,031 shares
@ $27.2441, valued at
$82.6k
Exercised 3,031 options to buy
@ $3.02, valued at
$9.2k
|
|
| 08/22/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 4,588 shares
@ $31.19, valued at
$143.1k
Exercised 3,755 options to buy
@ $8.27, valued at
$31.1k
Exercised 833 options to buy
@ $11.35, valued at
$9.5k
|
|
| 08/16/2023 |
4
| MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $30.9467, valued at
$309.5k
Sold 15,000 shares
@ $30.9467, valued at
$464.2k
|
|
| 08/15/2023 |
4
| Hunt Hazel (Chief Scientific Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 20,455 shares
@ $30.885, valued at
$631.8k
|
|
| 08/09/2023 |
4
| Hunt Hazel (Chief Scientific Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 29,545 shares
@ $30.48, valued at
$900.5k
Exercised 50,000 options to buy
@ $3.02, valued at
$151k
|
|
| 08/09/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 412 shares
@ $31.22, valued at
$12.9k
Exercised 412 options to buy
@ $8.27, valued at
$3.4k
|
|
| 08/09/2023 |
4
| Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 2,200 shares
@ $30.14, valued at
$66.3k
Sold 650 shares
@ $30.155, valued at
$19.6k
Exercised 2,200 options to buy
@ $6.55, valued at
$14.4k
Exercised 650 options to buy
@ $5.86, valued at
$3.8k
|
|
| 07/19/2023 |
4
| Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Exercised 10,000 options to buy
@ $1.92, valued at
$19.2k
|
|
| 07/18/2023 |
4
| BAKER G LEONARD JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC |
| 06/16/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 600 shares
@ $0 |
|
| 06/12/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 725 shares
@ $0
Gifted 650 shares
@ $0
Gifted 725 shares
@ $0 |
|
| 06/07/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $23.6, valued at
$236k
Exercised 10,000 options to buy
@ $11.35, valued at
$113.5k
|
|
| 06/05/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 2,091 shares
@ $22.97, valued at
$48k
Granted 2,091 shares
@ $0 |
|
| 06/05/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,411 shares
@ $22.97, valued at
$32.4k
Granted 1,411 shares
@ $0 |
|
| 06/05/2023 |
4
| Mokari Atabak (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,651 shares
@ $22.97, valued at
$37.9k
Granted 1,651 shares
@ $0 |
|
| 06/05/2023 |
4
| Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,658 shares
@ $22.97, valued at
$38.1k
Granted 1,658 shares
@ $0 |
|
| 05/23/2023 |
4
| BAKER G LEONARD JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| Alton Gregg H (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| Park Kimberly (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| WILSON JAMES N (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 80,000 options to buy
@ $24.1, valued at
$1.9M
|
|
| 05/23/2023 |
4
| MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| Cannon Gillian (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/23/2023 |
4
| Murray Joshua M. (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $24.1, valued at
$723k
|
|
| 05/11/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 30,000 shares
@ $23.87, valued at
$716.1k
Sold 14,000 shares
@ $24.07, valued at
$337k
|
|
| 05/09/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 60,586 shares
@ $24.07, valued at
$1.5M
Exercised 45,000 options to buy
@ $1.92, valued at
$86.4k
Exercised 60,000 options to buy
@ $3.29, valued at
$197.4k
|
|
| 05/09/2023 |
4
| MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Exercised 30,000 shares
@ $1.74, valued at
$52.2k
Paid exercise price by delivering 2,197 shares
@ $23.76, valued at
$52.2k
Exercised 30,000 options to buy
@ $1.74, valued at
$52.2k
|
|
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|